On March 22, Dr. Yao-chang Xu, CEO of Abbisko, attended the first Hong Kong Biotech Summit 2018 held by HKEX, when HKEX was revising its listing rules for biotech companies. As a representative of innovative platform-based biotech companies, Abbisko participates in and actively watches the impacts of the rule changes on life science companies and the trends in the industry’s future development.